Načítá se...
Fluconazole in the treatment of Cushing's disease
Ketoconazole was a first-line agent for suppressing steroidogenesis in Cushing's disease. It now has limited availability. Fluconazole, another azole antifungal, is an alternative, although its in vivo efficacy is unclear. A 61-year-old female presented with weight gain, abdominal striae and wo...
Uloženo v:
| Vydáno v: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bioscientifica Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744941/ https://ncbi.nlm.nih.gov/pubmed/26858837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0115 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|